Chemical specificity

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

Thursday, April 8, 2021 - 1:02pm

In contrast, Talem has developed the TATX-112 antibodies with the goal of specifically blocking the interaction between the target and its ligand, e.g.

Key Points: 
  • In contrast, Talem has developed the TATX-112 antibodies with the goal of specifically blocking the interaction between the target and its ligand, e.g.
  • That higher specificity is expected to increase the therapeutic window by lowering the potential risk of side effects and positively impacting treatment efficacy.
  • Additionally, the targets expression profile makes this membrane protein a promising candidate for antibody-drug conjugate-based therapies.
  • Alzheimers and other neurodegenerative diseases are associated with reduced expression levels of the target and impaired receptor signaling.

Insights Into the World Market of Food Enzymes, 2019 to 2026 | by Type, Application & Source

Tuesday, October 22, 2019 - 4:44pm

According to this report, the global food enzymes market size was $1,944.8 million in 2018, and is projected to reach $3,056.9 million by 2026, registering a CAGR of 5.6% from 2019 to 2026.

Key Points: 
  • According to this report, the global food enzymes market size was $1,944.8 million in 2018, and is projected to reach $3,056.9 million by 2026, registering a CAGR of 5.6% from 2019 to 2026.
  • Developments in protein and genetic engineering have resulted in the improvement of economy, specificity, stability, and overall application potential of food enzymes.
  • The application of enzymes in food processing is governed by various national and international agencies across the world.
  • Clean labels, immobilized enzyme technology, and sustainability are the some of the emerging food enzymes market trends around the world.